Picture of Applied Biosciences logo

APPB Applied Biosciences Income Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Annual income statement for Applied Biosciences, fiscal year end - March 31st, USD millions except per share, conversion factor applied.

2015
March 31st
2016
March 31st
2017
March 31st
2018
March 31st
2019
March 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue000.0460.1980.707
Cost of Revenue
Gross Profit0.0390.0420.185
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses0.0170.0280.5612.583.35
Operating Profit-0.017-0.028-0.516-2.39-2.65
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes-0.017-0.028-0.516-2.39-2.68
Net Income After Taxes-0.017-0.028-0.516-2.39-2.68
Minority Interest
Net Income Before Extraordinary Items
Net Income-0.017-0.028-0.518-2.38-2.63
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income-0.017-0.028-0.518-2.38-2.63
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-0.022-0.001-0.012-0.098-0.221
Dividends per Share